Concepedia

Roshan Dias

RD

Statistics

Publications

2

Citations

42

H-Index

2

Active since

2021

Affiliations

Alvotech (Germany)(Current)

Roshan Dias is an author at Alvotech (Germany) specializing in immunotherapy safety, pharmacy, and pharmacokinetics.

Publications per year

2021–2022

2

Publications

2

Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

Steven R. Feldman, Nataliya Reznichenko, Grażyna Pulka et al. · BioDrugs · 2021 · 31 citations · Full text

, , +15

A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST)

Christopher Wynne, Christian Schwabe, Charlotte Lemech et al. · Expert Opinion on Investigational Drugs · 2022 · 11 citations · Full text

, , +17

1–2 of 2